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Abstract: 
The innate immune response is vital in an organism’s ability to fight infection. Aspects of 
the innate immune response including inflammation, phagocyte populations, and the production 
of reactive oxygen species (ROS) must be closely regulated in order to effectively eliminate 
pathogenic entities. Dysregulation of the innate immune response can cause various pathologies, 
including chronic infection, autoimmunity, and cancer. Recent studies have shown that 
microRNAs (miRs) play a regulatory and “fine-tuning” role in the innate immune system of the 
Zebrafish.99 We have found that the expression of miR-199 is significantly upregulated upon 
stimulation of the Zebrafish innate immune system with Pseudomonas aeruginosa infection. 
Knocking-down the expression of miR-199 using oligonucleotide morpholino injection led to a 
significant decrease in bacterial burden of fish infected with P. aeruginosa as well as a 
significant increase in overall survival. Overexpression of miR-199 using a mature miR-199 
duplex led to a decrease in overall reactive oxygen species (ROS) within an infected organism. 
Recent data also suggest that direct targeting of Src family kinase (SFK) Lyn by miR-199 may be 
responsible for the immunosuppressant characteristics of this specific microRNA. 
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Introduction: 
 As human beings, we are exposed to a wide variety of pathogenic entities on a regular 
basis. Whether those pathogens are of viral or bacterial origin, we rely on our immune system to 
clear the infection. The human immune system is composed of two branches, the innate immune 
response and the adaptive immune response. The innate immune response is a rapid and non-
specific response to a wide variety of invading pathogens and is active in humans within the first 
12 hours of infection. The adaptive immune response is a more specific response and is 
associated with antibody production, memory T cells and memory B cells and is active 1-5 days 
post infection in humans. While both branches of immunity are worthy of investigation, our 
efforts are focused on the innate branch of the immune system due to the fact that it is an 
organism’s first line of defense against an invading pathogen and is integral in the establishment 
of a robust and efficient overall immune response.  
The zebrafish (Danio rerio) has become a valuable model organism for studying the 
innate immune system due to the fact that within the first 4-6 weeks of development the fish 
solely possesses an innate immune response. The zebrafish is also a valuable model in which to 
study chronic diseases that dysregulate the immune system such as Cystic Fibrosis. Cystic 
Fibrosis or CF is a multi-organ disease that is caused by mutations in the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene. The CFTR gene is conserved within the 
zebrafish genome and makes this organism a valid model to study CF. CF is known to be 
immunocompromising and is complicated by bacterial infections. These bacterial infections are 
commonly caused by P. aeruginosa and can become chronic and persistent, leading to increased 
morbidity and mortality. Our research is directed towards the gene-environment interactions that 
are associated with CF disease and its progression.  
	  
	  
2 
 To investigate this complex gene-environment interaction in the context of innate 
immune system a large RNAseq/small RNAseq analysis was completed. The RNAseq analysis 
cross-examined genomes from zebrafish depleted of CFTR via oligonulceotide morpholino, 
exposure to environmentally relevant As, and infected by P. aeruginosa. The data retrieved from 
this large data set identified the dysregulation of miR-199 in As exposed and CFTR depleted 
samples, specifically during infection or stimulation of the innate immune response. miRs are 
known to play important roles in many human pathologies and have recently been implicated in 
the immune system.99 Therefore, the focus of this paper is to identify the role of miR-199 in the 
context of innate immunity.  
Literature Review: 
Overview of Immunity 
	  
 Microorganisms are present throughout the environment and can exist in soil, water, on 
abiotic surfaces, and as commensal species within the normal human flora. Commensal bacteria 
are critical in the physical barriers of the host as they function to protect the host from external 
pathogens. These bacteria and other environmental microbes which are typically non-infectious, 
may become pathogenic following perturbation to the host1. Wounds, disease, and previous 
infections are potential mechanisms by which an opportunistic pathogen might cause disease. 
Opportunistic pathogens and other foreign invaders are constantly challenging host survival. 
Humans and upper level vertebrates possess an immune system composed of two main branches, 
the innate immune system and the adaptive immune system. All multicellular organisms possess 
an innate immune system. This rapid and immediate response is an organism’s first line of 
defense and is established immediately upon exposure to a foreign pathogenic entity. The innate 
	  
	  
3 
immune response is also characterized as a non-specific response and is therefore capable of 
recognizing and eliminating a broad range of invaders.  
 Nearly 500 million years ago vertebrates, jawed fish and jawless fish, such as lampreys 
and hagfish, evolved a secondary branch of immunity, known as the adaptive immune 
system2,3.The adaptive immune system, distinguishes itself from innate immunity in its ability to 
recognize specific antigens and its capacity to form immunologic memory. Memory recalls 
specific pathogens upon subsequent exposure and enables a quicker, more specific response as 
compared to the response to the primary infection. In contrast to the immediate nature of the 
innate immune response, mounting an adaptive immune response takes significantly more time. 
In humans, primary infections require 7-14 days to elicit an effective adaptive immune response. 
Cellular components of the adaptive immune system include T-cells and B-cells. T-cells mature 
in the thymus and act via cell-mediated immunity, sensing “self” from “non-self” on the surface 
of antigen presenting cells (APCs). B-cells mature in the bone marrow and participate in humoral 
immunity by recognizing foreign antigens and undergoing clonal selection, expansion, and 
differentiation into memory cells or plasma cells4. The innate and adaptive immune systems must 
work synergistically to defend the host; therefore, an effective adaptive immune system requires 
a strong innate immune response.  
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Figure 1: Basic overview of both branches of the immune system and their associated cell types 
(Fisher et. al 2011).  
Innate Immunity 
	  
 The innate immune system is evolutionarily intrinsic to eukaryotes and acts as the first 
line of defense against invading pathogenic entities. Innate immunity utilizes temperature, pH, 
chemical inhibitors, as well as physical, inflammatory, and phagocytic barriers to protect the 
host4. The primary functions of the innate immune system are to recruit immune cells to the site 
of infection, establish an inflammatory response, and activate the adaptive immune system. If 
any of these functions are dampened or inhibited, the infected organism is at greater risk for 
complication or death associated with infection. 
When a pathogen successfully bypasses the physical barriers of a host, such as the skin 
and mucosal layers, pathogen-associated molecular patterns (PAMPs) expressed on its surface 
	  
	  
5 
are recognized by host pattern recognition receptors (PRRs) found on various host cell types. 
Some common PAMPs include lipopolysaccharide (LPS), lipoproteins, bacterial double stranded 
DNA (dsDNA) (i.e. CpG motifs), viral single stranded RNA (ssRNA), and viral dsRNA5. These 
PAMPs enable the innate immune system to distinguish self from non-self and mount an 
appropriate response. PRRs recognize foreign molecules through two classes of receptors, 
membrane bound and cytosolic. Toll-like receptors (TLRs) and C-type lectin receptors (CLRs) 
represent the membrane bound receptors, whereas Retinoic acid-inducible gene (RIG)-I-like 
receptors (RLRs) and NOD-like receptors (NLRs) are cytosolic receptors6. Each of these 
receptors functions through recognition of different types of PAMPs and activate downstream 
signaling components of the innate immune system. 
The TLR family is among the most widely studied of the PRRs. This transmembrane 
protein family consists of numerous homologues and binds particular PAMPs from bacteria, 
viruses, and fungi. Receptor-ligand binding leads to complex downstream signaling and the 
production of proinflammatory cytokines as well as co-stimulatory molecules essential for the 
activation of the adaptive immune system. TLR signaling upregulates the transcription factor 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF- κB), which regulates the 
immune response to infection by inducing expression of cytokines such as tumor necrosis factor 
α (TNF-α), IL1, and IL6. Cytokines play an essential role in the inflammatory response as their 
signals lead to recruitment of immune cells, vasodilation, temperature increase, and further 
propitiate the inflammatory response6. Inflammation is one characteristic of the innate immune 
system that limits the spread of pathogens via the recruitment of immune cells to the site of 
infection.  
Activation and migration of immune cells such as neutrophils, macrophages, eosinophils, 
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mast cell, and dendritic cells to the site of infection is integral to pathogen elimination. 
Eosinophils and mast cells contain cytoplasmic granules with inflammatory and antimicrobial 
components. Stimulation of these cells by foreign antigen induces the release of granule contents 
into extracellular space to combat infection7. Dendritic cells play an integral role in immunity in 
that they phagocytose foreign pathogens and signal the adaptive immune response via antigen 
presentation. These antigen presenting dendritic cells serve as a link between the two branches of 
immunity7. Macrophages and neutrophils are professional phagocytes that internalize foreign 
bodies and apoptotic cell corpses, ultimately leading to their destruction. Phagocytosis is a 
receptor-mediated process that employs PAMP-PRR interactions to internalize pathogens. 
PAMP recognition by phagocytic cells involves receptors such as, TLRs, mannose, CD14, and 
scavenger receptor A (CD204)8. Once foreign bodies or debris are internalized, a vacuole, 
termed phagosome, undergoes a series of fusion and fission events with components of the 
endocytic pathway9. The maturation of the phagosome involves late endosome and lysosome 
fusion, leading to mature phagosomes and phagolysosomes, respectively. As phagolyosomes 
mature, the vacuole becomes acidic and contains anti-microbial peptides necessary for the 
destruction of engulfed pathogens8. The mature phagolyosome contains highly oxidizing 
components associated with nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. 
The release of these oxidizing components within the immune cells contributes to an immune 
phenomenon known as a respiratory burst. The ability of a host to produce a respiratory burst 
suggests the capability of mounting a robust innate immune response.  
Reactive oxygen species (ROS) and nitrogen species (RNS) are involved in the highly 
oxidizing environment of the phagolyosome and are essential for the clearance of bacterial and 
fungal infections via respiratory burst8. ROS includes superoxide radicals, hydrogen peroxide, 
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and hydrochlorous acid, all of which are formed by pre-existing components of NADPH 
oxidase8. Although both ROS and RNS destroy pathogens through cell membrane destruction, 
DNA damage, and protein disturbance, the formation of nitric oxide must be catalyzed, as it is 
not a pre-existing component of NADPH oxidase. This catalytic activity is controlled by 
inducible nitric oxide synthase 2 (iNOS). iNOS gene expression is activated by proinflammatory 
cytokine stimulation in immune cells. iNOS activity yields NO-, a toxic radical, that can readily 
react with ROS to produce various toxic reactive nitrogen intermediates (RNI), leading to 
pathogen elimination. Additionally, a recent study by Yoo et al suggests that the Src family 
kinase (SFK) Lyn is involved in the recruitment and activation of neutrophils in response to 
stimulation of the innate immune system and the production of ROS. (Yoo et al) 
The innate immune system, with its anatomic, physiologic, inflammatory, and 
phagoctytic barriers, provides essential protection of organisms. The activation and suppression 
of the innate immune response requires tight regulation of immune-related genes and cytokines. 
Abnormal gene expression in response to foreign pathogens affects different facets of the innate 
immune response. In some cases, gene dysregulation can enhance disease progression and lead 
to chronic infections. Gene regulation is under the control of a wide variety of signaling 
cascades, enzymes, transcription factors and microRNAs (miR). MiRs have recently come to 
light as key players in the control of biological and physiological processes. These biological 
regulators influence gene expression post-transcriptionally through transcript degradation, 
translational repression, and in rare cases, translational activation10. Gene regulation by miRs has 
been shown to serve a functional role in human diseases, such as immune related diseases, 
cardiovascular disease, Alzheimer’s disease, and many cancers11–15. The ability to fight infection 
relies on strict gene regulation; this relatively new class of regulators may help elucidate the 
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mechanism by which genes are being regulated during immunity, possibly contributing to new 
gene therapies.  
	  
Pseudomonas aeruginosa 
 
P. aeruginosa, an opportunistic human pathogen, is one of the leading causes of hospital 
infections and is responsible for increased morbidity and mortality in Cystic Fibrosis (CF) 
patients. P. aeruginosa causes both acute and chronic infections in a wide diversity of animals 
and plants85. This Gram-negative bacterium can be found naturally in water, soil, and as 
commensal skin flora. P. aeruginosa typically infects immunocompromised hosts; however, 
clinically significant infections, e.g. keratitis, skin, respiratory tract, and bloodstream infections, 
have been documented in otherwise healthy individuals. The ability for P. aeruginosa to evade 
host immunity, as well as its intrinsic resistance to antibiotics, makes this bacterium difficult to 
treat and eradicate as a human pathogen86.  
P. aeruginosa contains several surface structures including a lipopolysaccharide (LPS) outer 
membrane, single polar flagellum, Type IV pili, and chaperone pili, all of which are recognized 
by the immune system86.  LPS, predominantly the lipid A component and a structural variation 
of the O-antigen, is critical in P. aeruginosa infections as it impacts both virulence and host 
immunity. LPS is recognized by TLR4 in mammals to stimulate an innate immune response. 
TLR4-LPS interaction commences a downstream signaling cascade that acts notably through 
NF-kB to produce pro-inflammatory cytokines such as IL-1, IL-6, IL-8, and TNF- α 87.  The NF-
kB pathway can also be activated by TLR5 and TLR2 signaling in response to bacterial flagellin 
and LPS/lipoproteins, respectively77,88. Duplication events to the zebrafish genome resulted in 
two copies of TLR4, tlr4a and tlr4b. LPS stimulation in the zebrafish was not recognized by tlr4, 
indicating a tlr4 independent pathway for LPS in zebrafish75. Other TLRs have shown 
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conservation between humans and lower level vertebrates. TLR5, is conserved in vertebrates 
from fish to human76–78. TLR5 also underwent a duplication event in the zebrafish, yielding tlr5a 
and tlr5b. TLR9 also appears to have conservation with zebrafish tlr9 (Luc, unpublished). P. 
aeruginosa has evolved ways to evade the immune response, treatments, and increase its 
virulence through various virulence factors in addition to LPS.  
P. aeruginosa, like other Gram-negative bacteria, utilizes secretion systems to disseminate 
proteins and other toxins to enhance virulence. P. aeruginosa uses two types of secretion systems 
type II and type III, denoted T2SS and T3SS. T2SS utilizes Xcp and Hxc to mediate secretion of 
proteases, lipase, and toxins into the extracellular medium or onto the surface of the 
bacterium86,89. T3SS uses a needle complex and translocation apparatus to secrete proteins such 
as exoenzymes (ExoU, ExoT, and ExoS) directly into the eukaryotic host cell86,90. These proteins 
help the bacterium inhibit inflammasome activity, and target host proteins involved in 
phagocytosis, endocytic trafficking and immune cell migration86. Additionally, this catalase- 
positive bacterium has the ability to neutralize hydrogen peroxide, an otherwise toxic ROS 
produced by professional phagocytes91. The arsenal of virulence factors of P. aeruginosa makes 
this bacterium very difficult to treat, leading to persistent and recurring infections, especially in 
CF patients. 
 CF is a congenital disease that is caused by malfunction of chloride channels encoded by 
the cystic fibrosis transmembrane conductance regulator gene (CFTR). This disease is most 
commonly associated with the lungs; however, it is a multi-organ disease affecting the pancreas, 
small intestine, and the liver92. Despite extensive antibiotic therapy, CF patients are prone to 
persistent P. aeruginosa infections. The low membrane permeability of P. aeruginosa bacteria 
coupled with the presence of an efflux pump increases antibiotic resistance and makes this 
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bacterium difficult to treat 93,94. P. aeruginosa persists in these patients by forming biofilms, 
which are produced through the release of exopolysaccharides, which enable microcolonies to 
attach to surfaces and encase in a biopolymer matrix. Biofilm growth protects P. aeruginosa 
from destructive immune components. Colonization of P. aeruginosa coupled with biofilm 
production and an increase in antibiotic resistance enhances the morbidity and mortality of CF 
patients with persistent infections.  
 The prevalence of P. aeruginosa infections in nosocomial settings and with CF patients 
has led to the extensive investigation of pathogenesis. However, increased evidence of antibiotic 
resistance and immune evasion warrants investigation of the host response. Understanding of the 
host response, including gene regulation, upon bacterial infection could potentially lead to gene-
targeted therapeutics. This paper will show a potential functional role for miR-199 during 
bacterial infections using the zebrafish model.  
Zebrafish as a model organism 
 
Animals are commonly used to study basic biological processes and to model human disease 
states. The zebrafish has become a valuable vertebrate model for basic and translational research. 
Since the 1970s, beginning with the work of Dr. George Streisinger, the zebrafish model has 
been used to explore cardiovascular, muscle, toxicant, and pathogen studies. The zebrafish model 
system has many benefits, which include ex utero fertilization, fast generation time, large sample 
sizes, optically clear embryos, an annotated genome, and amenability to genetic manipulation 
50,51,66. As a result of the zebrafish sequencing project, we now know that there are many genetic 
similarities between zebrafish and humans, making zebrafish an attractive model for use in the 
investigation of biomedical science research. In annotating the zebrafish genome, researchers 
found 70% of protein-coding human genes were related to genes in the zebrafish59. Further, it 
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was found that 84% of human genes associated with disease had a zebrafish counterpart59. With 
such high genomic conservation, particularly in relation to genes associated with disease, 
zebrafish have become a useful model in which to explore questions related to human health. 
Advantages of the zebrafish model system, as well as biomolecular tools, have given researchers 
the ability to make observations and answer questions using zebrafish that could not be answered 
in other model systems.  
The genetic amenability of the zebrafish has allowed for the generation of transgenic and 
mutant zebrafish lines as well as the evaluation of specific gene or miR function by using 
morpholino oligonucleotide (MO) knockdown applications. Transgenic reporter lines, such as 
Tg(mpx:EGFP) and Tg(mpeg1:mcherry), use gene promoters to drive the expression of 
fluorescent proteins and aid in study of the innate immune system by allowing for in vivo 
visualization of neutrophils and macrophages, respectively. Functional roles for specific gene 
products can be determined in zebrafish by employing tools such as MOs to knockdown 
expression of genes of interest60. MOs accomplish targeted gene “knockdown” via sterically 
blocking the region of interest and preventing either protein synthesis or messenger RNA 
(mRNA) splicing of transcripts. MOs can be used to prevent the synthesis of mature miRs by 
binding to the particular transcript of interest within the pri-miR complex and my also binding 
the cleavage sites for either Drosha or Dicer. 
One unique hallmark of the zebrafish model in the context of disease is the temporal 
separation of their innate and adaptive immune systems. Adaptive immune markers are not 
present until 4 days post fertilization (dpf) and a fully functioning adaptive immune system is not 
observed until 4-6 weeks post fertilization 61. This characteristic of the zebrafish allows for the 
direct observation of the innate branch of the immune system in zebrafish embryos and larvae. 
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The isolation of the innate immune system gives researchers a model to study the first line of 
defense, without the complication of adaptive immunity. Key components of the innate immune 
system, such as phagocytes, complement factors, and anti-microbial peptides, are all present in 
the zebrafish embryo during early development62,63. Phagocytes are present in the zebrafish by 
48 hpf, with macrophages differentiating from HSC first at 18 hpf, followed by neutrophils 
between 30 hpf 64,65. Zebrafish respond to microbes in a similar fashion to the mammalian model 
with recognition through PAMP-PRR interactions. Many signaling transduction components of 
the mammalian TLR pathways are present in the zebrafish, including putative mammalian 
orthologs for the TLR receptors and their cytoplasmic adaptor proteins, such as Myd88, TIR-
domain-containing adapter-inducing interferon-β (TRIF)74.  
The above studies are examples of how the zebrafish model has gained ground as a model for 
inflammatory and infection states. Many other research studies have proven zebrafish to be an 
ideal model for infectious disease 79–83. Additionally, the optical clarity of zebrafish embryo has 
enabled the observation of host interaction with infectious disease in real time, including 
chemotaxis, phagocytosis, and pathogenesis84. The zebrafish has been used to model viral, 
fungal, and bacterial infections. To date the zebrafish has served as a disease model for bacterial 
infections such as Edwardsiella tarda, Mycobacterium haemophilum, Salmonella typhimurium, 
Staphylococcus aureus, and Pseudomonas aeruginosa (P. aeruginosa) 79–83.  
Immersion, duct of Cuvier (DC) injections, and tail vein injections can all cause a 
systemic infection in zebrafish, whereas, hindbrain injections into closed ventricles result in a 
localized infection 84. Clatworthy et al. demonstrated that injection of P. aeruginosa into 
zebrafish circulation leads to a lethal infection83. The establishment of a bacterial model for P. 
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aeruginosa in the zebrafish allows for the study of bacterial pathogenesis in the context of a 
human disease Cystic Fibrosis (CF) and the innate immune response. 
MicroRNAs  
	  
MicroRNAs (miRs) are short, endogenously expressed; non-coding single-stranded RNA 
(ssRNA) fragments, typically 22-24 nucleotides in length. MiRs were first discovered in 1993 by 
Victor Ambros and colleagues Rosalind Lee and Rhonda Feinbaum, during heterochronic studies 
in Caenorhabditis elegans (C. elegans) 16. Lin-4 was discovered to have an essential role in 
normal temporal C. elegans development; however, lin-4 is non-protein coding, a phenomenon 
determined through site-directed mutagenesis. The sole function of Lin-4 expression is to 
negatively regulate lin-14, a protein-coding gene whose timed expression is also vital in 
nematode development. Sequence complementarity between lin-4 and the 3’ untranslated region 
(UTR) of lin-14 showed RNA-RNA interaction leading to decreased lin-14 protein expression, 
while lin-14 transcript levels remained the same 16. The discovery of non-coding RNA fragments 
that regulate gene expression post-transcriptionally, were originally thought to be unique to C. 
elegans. The presence of these small non-coding RNAs, later coined miRs, have now been found 
in a vast variety of entities from low level organisms, such as sponges, to high level vertebrates 
and humans 17.  
MiR Biogenesis 
	  
MiRs are well-conserved amongst different organisms, which include worms, flies, and 
mammals 18–20. The biogenesis of miRs follow a similar canonical pathway in most species 
beginning in the nucleus with a long primary miR transcript (pri-miR) transcribed with the help 
of RNA polymerase II (Bartel et al). The transcription of pri-miR stems from intergenic, intronic, 
and exonic regions of the genome 21. The biogenesis of mature miRs is initiated by Drosha, an 
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RNase III endonuclease, which recognizes tertiary structure, as opposed to sequence motifs, and 
cleaves pri-miR into a shorter stem-loop precursor ~70 nucleotides, known as pre-miR22,23. 
Drosha, a large 160kDa protein, contains two RNase III domains and a double stranded RNase 
binding domain (dsRBD) needed for proper processing 24. This RNase III endonuclease is 
usually accompanied by a cofactor known as DiGeorge syndrome critical region gene 8 
(DGCR8) in vertebrates or Pasha in invertebrates to form a microprocessing complex 22–24. The 
biochemical role of this cofactor is not fully understood; however, it is believed to aide Drosha in 
substrate recognition. Drosha cleavage results in pre-miR with a~22 nucleotide stem, a terminal 
loop, and a 3’ overhang of ~2 nucleotides. This structure was shown by Cullen et al to be an 
important pre-miR structural requirement 25.  Following nuclear processing the intermediate 
product of Drosha, pre-miR, is then exported via Ran-GTP dependent Exportin 5 26. Once in the 
cytoplasm pre-miR is subjected to additional cleavage via another RNase III endonuclease, Dicer 
23. Dicer completes cytoplasm cleavage of pre-miR into a mature miR duplex. The long N-
terminal segment of Dicer contains a PAZ (Piwi Argonaut and Zwille) domain. This PAZ 
domain can also be found in a highly conserved group of proteins known as argonaute proteins 
(Ago), which bind to the 3’ protruding end of the stem-loop structure created by Drosha cleavage 
in the nucleus 22. Ago proteins do not appear to be required for Dicer cleavage; however, their 
role may be in providing stability via effector complex formation. Dicer cleaves pre-miR hairpin 
structures, forming a miR-duplex containing 5 and 3 prime arms, denoted 5p and 3p. Helicases 
present in the cytoplasm unwinds the miR-duplex structure separating the 5p and 3p arms. The 
miR arm with the higher thermodynamic instability at the 5’ end of the fragment is typically 
incorporated into the RNA inducible silencing complex (RISC) with the help of Ago, forming an 
effector complex 22,27.  The other strand of the duplex is normally degraded, as it is not stabilized 
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with RISC effector complex incorporation. In some cases both arms of the duplex are expressed 
or a different arm is incorporated depending on tissue specificity, a phenomenon known as “arm 
switching” 28,29. The mature miR and effector complex regulate genes post-transcriptionally 
through RNA-RNA interactions in 3’ UTR of gene transcripts10. Although miRs are 22-24 
nucleotides in length their RNA-RNA interactions post-transcriptionally are not solely dependent 
on complete complementarity (Figure 1). 
	  
Figure 2. The biogenesis of miRs. Modified from Szabo et al. 2010.  
 
	  
	  
16 
Targeting of MiRs 
	  
 Typically 6-8 nucleotides within the miR fragment, exhibiting Watson-Crick pairing is 
sufficient to target mRNA10. This region of RNA-RNA complimentarity is known as the miR 
seed region. The “seed” region located at the 5’ end of the miR is centered on nucleotides 2-7. 
MiR seed sites can be classified as 8mer-1A, 7mer-m8, or 7mer-1A in order of hierarchy 
depending on complementarity in the 2-7 seed region. The 8 mer-1A site is an exact match to 
nucleotide 2-8 followed by an adenine “A” in position 9, 7-mer-m8 is an exact match to 2-8nt, 
and 7mer-1A is an exact match to 2-7 followed by an adenine.  
The binding of miR to target sites is also influenced by other factors in addition to seed 
region complementarity, which include positioning within the 3’UTR; the location of stop 
codons; spacing between miR binding sites; and the secondary structure of target mRNA30,31. 
Base-pair complementarity of the complete miR:mRNA interaction increases the likelihood of 
endonucleolytic cleavage leading to mRNA degradation. Endonucleolytic cleavage of mRNA is 
tolerable to few mismatch base-pairings; however, even in the presence of perfect Watson-Crick 
pairing miR processing machinery such as Dicer, Ago, RISC, and the interaction of other 
proteins may be required for successful degradation 32–34.  
The binding of miRs within the 3’UTR region of target genes may also prevent gene 
expression through inhibition of proper translation. Cytoplasmic mRNA transcripts are translated 
into protein via ribosome initiation, elongation, and termination. Studies show some miR 
targeted mRNA remain as polysomes, which suggests that translational repression of miR occurs 
after ribosome initiation31. The interaction of miR:mRNA can also occur at the 5’UTR of target 
genes showing repression and activation results35. The mechanism of miR activation remains 
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poorly understood; however, it appears to be mediated by Ago proteins35. The large scope of 
possibilities that influence miR:mRNA interactions allow for specific control of gene regulation. 
 Imperfect binding at the 3’ UTR of gene transcripts allows for one single miR to bind 
and regulate the expression of hundreds to thousands of gene products. MiRs also have the 
ability to bind a single transcript more than once and a single transcript can be targeted by 
multiple miRs 36,37. MiRs that bind target sites with complete complementarity or base pairing 
within the seed region improve the likelihood of bona fide targets. Genome-wide computational 
searches, such as Targetscan, have developed a method using experimental requirements of bona 
fide miR:mRNA interactions; taking into account the complexity of miR binding and 
conservation of sites to allow for algorithm target predictions 20,22,38–40. These resources allow for 
identification of putative targets and target sites for a given miR or gene input. Genome wide 
computational searches have enabled the identification of 1881 miRs in the human genome, a 
drastic increase since their discovery in 1993 20,41–44. 
MiRs in Immunity 
	  
 The 1881 miRs identified in the human genome are believed to regulate upwards of 60-
80% of human gene expression 20,41. Precise control of gene expression is vital for of 
homeostasis throughout the body. Physiological and pathological issues can arise in the absence 
or inability of a system to return to homeostasis after disruption. The discovery of miRs 
introduces a new class of regulators that may help answer underlying questions regarding the 
regulation of genes involved in disease progression, immunity, and other cellular processes. 
Expression profiles of miRs have been described in a wide range of tissues and aberrant miR 
expression profiles have been associated with at least 70 diseases  (Table 1) 39,45. 
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Disease/ Inflammation 
Type 
miR References 
Cardiac hypertrophy  miR-23a, miR-23b, miR-
24, miR-195, miR-199a, 
and miR-214 
11 
Rheumatoid arthritis miR-155, miR-146 12 
Type 1 diabetes miR-510  
Type 2 diabetes miR-146a  
Bacterial infection miR-155  
Myeloproliferative 
disorders 
miR-125b, miR-155, miR-
146a 
 
Alzheimers miR-9, miR-128a, miR-
125b 
13 
  
Whether miRs functioned within the immune system was examined in experiments where 
miR biogenesis was altered. The conditional deletion of Dicer, a cytoplasmic endonuclease 
essential for the production of mature miRs, prevents hematopoietic stem cells (HSCs) from 
reconstitution in the mouse model46. HSCs are typically able to renew themselves and give rise 
to new blood cells, including immune progenitor cells needed for the establishment of both 
innate and adaptive immune cells. The deletion of dicer in T and B-lymphocytes led to fewer T-
cells in the thymus and periphery, while also inhibiting B-cell development47. Furthermore, 
knockout of Ago2, the protein responsible for stabilizing the RISC complex in HSCs, impaired 
B-cell and erythroid differentiation48. The inhibition of miRs at the level of biogenesis drastically 
impacted immune cell progenitors, indicating a role for miRs in the immune system.  
An ongoing task is now identifying the functional roles of individual miRs. The use of 
microarrays, deep sequencing, and other bioinformatics approaches has led to key findings 
regarding miR expression within the immune system. As of 2012, upwards of 100 miRs were 
found to be expressed in cells destined for the immune response 49. Aberrant miR expression 
profiles in various malignancies and infection states have indicated a potential role for individual 
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miRs in mammalian immunity. miR-155 and miR-146 have been extensively studied and have 
both shown important roles in the innate immune system.  
Profiled as a typical immune response regulator, miR-155 is a common target of broad 
range inflammatory mediators such as TNF and interferon (IFN) 48. MiR-155 expression is 
upregulated in monocytes, macrophage, and myeloid dendritic cells upon stimulation with LPS, 
IFNβ, and polyriboinosinic: polyribocytidylic acid (Poly(I:C)) 48,50–52. MiR-155 upregulation is 
initiated through the recognition of bacterial or viral PAMPs by TLRs and involves NF- κB and 
Jun N-terminal kinase (JNK) pathways in macrophage cells. Blocking the JNK pathway with 
chemical inhibitors prevented the upregulation of miR-155 following inflammation in murine 
macrophages50. O’Connell et al. identified Src homology-2 domain-containing inositol 5-
phosphatase 1 (SHIP1) as a direct 3’UTR target of miR-155 in the hematopoietic system53. 
Either SHIP1-deficiency or miR-155 overexpression in HSCs led to myeloproliferative 
phenotypes. The specific function of miR-155 in macrophage and HSCs still remains unclear. 
However, miR-155 has an apparent role in myeloid and lymphoid development as evidenced by 
the association between overexpression of miR-155 and myeloid proliferative disorders, such as 
myeloid leukemia 53. Dendritic cells deficient in miR-155 have an impaired ability to trigger T-
cell activation following antigen presentation; suggesting miR-155 may act as a “bridge” 
between the innate and adaptive immune systems54. 
 A role for miR-146 in the development and homeostatic control of myeloid and lymphoid 
cells has also been documented. MiR-146 was one of the first miRs to be identified in regulating 
the mammalian response to infection. MiR-146 is upregulated in immune cells upon stimulation 
with bacterial components such as LPS, as well as IL1 and TNF52,55. Bacterial infection in 
zebrafish induces miR-146 expression in a myeloid differentiation primary response gene 88 
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(MyD88)- TNF Receptor-Associated Factor 6 (TRAF6) dependent manner. Targets of miR-146 
include Interleukin-1 receptor-associated kinase (IRAK) and TRAF6, which play key roles in 
TLR and IL-1 receptor signaling pathways during innate immunity48. The downregulation of 
these pathways in the presence of miR-146 indicates that miR-146 is a negative regulator of 
inflammation. Human monocytes expressing miR-146 attenuate the expression of TNF, IL-6 and 
IL-1255.  
MiR-155 and miR-146 were originally identified as inflammation responsive miRs as 
both were upregulated by NF- κB. Upon further investigation, functional roles for each of these 
miRs were found within different facets of the innate immune system48. It is therefore likely that 
other miRs that regulate or respond to NF- κB will also play roles in the innate immune response. 
NF- κB is a transcription factor that induces the expression of many proinflammatory cytokines 
and thus contributes to the innate immune response as well as many inflammatory disorders. The 
NF- κB pathway is constitutively active, with high activity of IKKβ (an activator of NF- κB), in 
many cancers including breast cancer, melanoma, pancreatic cancer, and acute myeloid 
leukemia14. Inhibition of IKKβ prevents the translocation of NF- κB to the nucleus, thereby 
suppressing the transcription of proinflammatory cytokines. IKKβ, is a direct target of miR-199a 
in human epithelial ovarian cancer cells14, indicating a role for miR-199 in the NF- κB pathway 
and potentially the innate immune response. The functional role of miR-199 in the innate 
immune system has not yet been investigated in vivo.  
MiR-199 Family 
	  
 In humans, the miR-199 family consists of three members: Homo sapiens (hsa)- miR-
199a-1, miR-199a-2, and miR-199b; which yield mature sequences hsa- miR-199a-5p, hsa- miR-
199a-3p, and hsa- miR-199b-5p42,44.  In zebrafish, miR-199 also has three family members: 
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danio rerio (dre)- miR-199-1, dre-miR-199-2, and dre-miR-199-3, yielding mature sequences 
dre- miR-199-5p, dre- miR-199-3p, and dre- miR-199-3-3p42–44. The function of miR-199 has 
been studied in humans, mice, rats, and zebrafish. Many studies primarily focused on hsa-miR-
199a-5p, because previous literature suggested miR-199a-3p was degraded. However, 
microarrays have detected high expression of both miR-199a-5p and miR-199a-3p in various cell 
and tissue types, suggesting both mature sequences may play important functional roles. The 
extensive use of microarrays has shown aberrant expression of miR-199a in animal models of 
heart failure, lung fibrosis, cancer, and liver disease as well as expression during skeletal 
development, and the maintenance of mesenchymal stem cells14,56–59. 
 
Functional Roles for miR-199 in Human Health 
	  
 Animal models of heart disease have revealed a role for miR-199a-5p in cardiac 
myocytes, cardiac hypertrophy, and end stage heart failure59–61. Hsa-miR-199a-5p is 
downregulated during hypoxia preconditioning and early ischemia in cardiac myocytes60. 
Reduction of hsa-miR-199a-5p is required for the expression of hypoxia inducible factor 1 (HIF-
1 α). Hsa-miR-199a-5p knockdown during normoxia led to an upregulation of HIF-1α. 
Altogether, these data show that HIF-1α is a direct target of miR-199. Downregulation of miR-
199a-5p prior to hypoxia increased inducible nitric oxide synthases, (iNOS) production. This 
increase in iNOS was dependent upon the downregulation of miR-199a-5p and increased HIF-1α 
activity. Downregulation of hsa-miR-199a-5p reproduces a similar expression profile to that of 
hypoxia preconditioning, which could lead to protection against future hypoxic damage60.  
Significant upregulation of Rattus norvegicus (rno)-miR-199a-5p was found during 
cardiac hypertrophy. Rno-miR-199a-5p function contributes to the maintenance of 
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cardiomyocyte cell size and regulation of cardiac hypertrophy. HIF-1α is a potential regulator in 
cardiomyocyte development and is significantly downregulated with the overexpression of rno-
miR-199a-5p61. End stage failing adult human hearts and hypertrophic mouse hearts also 
displayed an overexpression of hsa-miR-199a-5p. Overexpression of hsa-miR-199a 
phenotypically alters cardiomyocytes to elongate and serially assemble59. MiR-199a can regulate 
signaling pathways by targeting transcription factors, such as NF- κB and Hif-1α, which 
influence proinflammatory cytokines and cell maintenance. 
 MiR-199a can also be regulated by signaling pathways such as transforming growth 
factor (TGF- β), a cytokine which plays a role in immunity and is known to induce the 
expression of miR-199a in fibrosis lung, kidney, and liver fibrosis models57,62. Inhibition of 
Caveolin 1 (CAV1), a target of miR-199-5p, altered the ability to endocytosis TGF-β receptors, 
promoting TGF-β signaling. MiR-199a-5p overexpression in lung fibroblasts enhances the 
ability of fibroblasts to migrate, proliferate, and differentiate into myofibroblasts62. Fibrosis is a 
typical result of inflammation in this case, perturbed by overexpression of miR-199. 
 Over expression of proinflammatory cytokines is a hallmark of cancer development. 
MiR-199a has been shown to play a role in proinflammatory cytokine expression and the 
development of	  ovarian cancer. Epithelial ovarian cancer (EOC) cells extracted from humans 
showed the dyregulation of hsa-miR-199a affected tumor progression, production of 
proinflammatory cytokines, and cell response to chemotherapy treatments such as cisplatin14,63. 
Gene expression profiles of ovarian cancer cells with different outcomes revealed IKKβ and 
rapamycin (mTOR) as potential targets of hsa-miR-199a. Hsa-miR-199a could act as a gene 
marker for ovarian cancers and help direct treatment approaches.  
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Microarray studies looking at various conditions such as: Schistosomiasis japonica infection 
in murine liver (45 dpi), aging Mesenchymal stem cells (MSCs) in rhesus monkeys, and the 
effects of perfluoroalkyl chemicals (PFCs) in human subjects, all revealed dysregulation of miR-
199. MiR-199-5p and 3p were both increased in Schistosomiasis japonica-infected murine livers, 
miR-199a-3p expression was decreased in aging MSC of rhesus monkeys, and serum levels of 
miR-199-3p were increased in humans exposed to PFCs58,64,65. Ex vivo studies have implicated a 
role for miR199 in human disease and within immune pathways such as NF- κB signaling. 
Despite numerous functional roles for miR-199 family members in animal health and 
inflammatory signaling, the role of miR-199 in innate immunity in vivo has yet to be investigated 
in the context of innate immunity in vivo.   
 
Materials and Methods: 
Zebrafish Maintenance  
 
 Adult zebrafish were maintained at 28 °C on a 16 hour light/ 8 hour dark cycle in the 
Zebrafish Facility at the University of Maine in Orono. Embryos were obtained from natural 
spawnings of Adult AB strain, Tg(mpx:GFP) and Tg(mpeg1:mCherry)84. Fertilized embryos 
were collected and placed in 50 ml of egg water (60 mg Instant Ocean sea salts/L) at 28°C 
incubation. New egg water was administered every 24 hours and non-surviving embryos were 
removed. For visualization purposes some embryos were manually dechorionated at 24 hours 
post fertilization (hpf) and subjected to egg water containing l-phenyl-2-thiourea (PTU) 
(1mg/ml) to prevent pigmentation. Embryo care and maintenance followed the guidelines set 
forth by the Institutional Animal Care and Use Committee at the University of Maine.  
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Microinjection of Morpholino Oligonucleotide 
 
Anti-sense microRNA morpholino oligonucleotides (MO) were designed using sequence 
information from the Sanger Institute's miRBase (Accession # MIMAT0003155) and 
synthesized by Gene Tools, LLC (Eugene, OR).  Oligonucleotides were diluted in 1× Danio 
buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM HEPES; 
pH 7.6) and 0.5% phenol red indicator (Sigma-Aldrich, St. Louis, MO). MOs were designed to 
the star strand and the dicer cleavage site on the star strand. MiR-199-3p 5’- 
TCTAACCAATGTGCAGACTACTGTA 3’-Fluorescein and  
MiR-199-1-3p 5’-TCTAACCAATGTGCAGACTACTGTA 3’ were complemented with 
standard MO 5′-CCTCTTACCTCAGTTACAATTTATA-3′. Fertilized embryos were injected in 
the yolk with approximately 2 nl (12 ng/nl) at the 1–2 cell embryonic stage and injected at 40–50 
psi. 
Bacterial injections 
 
 Pseudomonas aeruginosa infections were performed with Pa (p67t1), which 
constitutively expresses the fluorescent protein dTomato. P. aeruginosa (p67t1) was incubated 
overnight in Luria Broth (LB), 750 ug/ml ampicillin 85. Cultures were spun at 2450 x g for 5 
minutes at 4°C.  Pellets were resuspended and washed a total of three times in sterile 1X 
Dulbecco's phosphate buffered saline (DPBS) (Life Technologies). The optical density (A600 ) 
was measured and adjusted to 1.8 - 2 x 107CFU/ml. P. aeruginosa bacteria were prepared in a 
0.5% phenol red injection solution and diluted with DPBS. Zebrafish embryos were anesthetized 
in a 4 mg/ml tricaine solution (Western Chemical, Ferndale, WA) prior to infection at 48hpf. 
Fish were mock-infected with DPBS containing 0.5% phenol red. Fish were injected via the 
cardinal vein with 1.5 nl of solution for systemic evaluation and in the hindbrain ventricle for 
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localized infection. Injection volume of 1.5 nl was diluted in PBS and plated onto LB plates 
before and after bacterial injections to determine inoculum (CFU/ml). Fish injections were 
rotated between control and morphants to minimize change in inoculum size.  
Mortality 
 
 Zebrafish were subjected to four conditions, with 20 - 60 zebrafish embryos per 
condition. The conditions included: PBS Control MO, PBS miR-199 MO, P. aeruginosa infected 
Control MO, and P. aeruginosa infected miR-199 MO. The fish were monitored for 5 days post 
infection (dpi) for survival. Statistical analysis and the production of mortality curves were 
completed using the Mantel-Cox test with Prism 6 software. 
Bacterial Burden Assay 
 
Embryos were washed in 4 mg/ml tricaine solution 6 hours post infection (hpi). Single 
fish were then homogenized in 200 µl of PBS along with two 4.2 mm metal beads using a Bullet 
Blender at speed 8 for 2 minutes (Next Advance). Homogenates were diluted in PBS and plated 
onto Cetrimide agar to isolate P. aeruginosa colonies. Plates were incubated for 16 hours at 37 
°C. 
In Situ Hybridization  
 
 AB strain embryos were dechorionated 24hpf and treated with PTU (1 mg/ml). Embryos 
were fixed at 54 hpf with 4 % (wt/vol) paraformaldehyde (PFA) and washed in 1x PBS-Tween 
solution before being stored at 4 °C. For miRNA in situ, three washes of 1-­‐methylimidazole 
buffer (1-MIB) followed by treatment with 0.16M 1-­‐ethyl.-­‐3-.-­‐(3-.-­‐dimethyl-.-­‐aminopropyl) 
carbodiimide (EDC) were completed prior to dehydration steps (Sigma-Aldrich, St. Louis, 
MO)86. Embryos were washed 5 x 5 min with PBS-Tween and dehydrated 1 x5 min with the 
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following solutions: 33 % MeOH / 66 % PBS-Tween, 66% MeOH / 33 % PBS-Tween, and 100 
% MeOH before being stored for 48 hrs at -20 °C. Dehydrated embryos were treated with 
Proteinase K (Fisher) for 15 to 45 minutes and then fixed (20 minutes) in 4 % PFA and washed 5 
× 5min PBS-Tween. Embryos were incubated in prehybridization solution (50 % Formamide, 5 
× sodium chloride-sodium citrate buffer, 50 µg/mL heparin, 500 µg/mL yeast tRNA, 0.1 % 
Tween20, pH of 6.0 with citric acid) for 4 hours in 65°C water bath, and then hybridized 
overnight at 65°C with a fluorescein-labeled MO probe:  
MiR-199-3p 5’- TCTAACCAATGTGCAGACTACTGTA 3’ 
Embryos were washed in PBS-Tween, blocking buffer, then incubated in either anti-digoxygenin 
Ab or anti-fluorescence Ab (Roche) for 2 hours at RT. Embryos were then subjected to 
coloration buffer and developed in a 0.45 % NBT / 0.35 % BCIP (Roche) coloration buffer 
solution until desired color was achieved and fixed in 4 % PFA. Imaging was completed using a 
Zeiss Axio Imager Z1 microscope with a Zeiss ApoTome attachment.  
RNA extraction and cDNA synthesis 
 
 Ten zebrafish were collected from treatment at 1, 3 and 6 hpi.  TRIzol RNA extraction 
procedure was completed according to the manufacturer’s protocol. The extracted RNA was then 
analyzed for concentration using NanoDrop Ultra Violet spectroscopy. RNA template was 
diluted in nuclease-free water (NFW) to yield a RNA concentration of 0.5- 1µg/mL. Quanta 
miRNA cDNA synthesis kit was followed according to the manufacturer’s instructions. The 
reactions were then diluted 1:20 in 180 µL NFW for a final volume of 200µL cDNA. 
Quantitative PCR (qPCR) 
 
 Quantitative PCR was performed using PerfeCTa® SYBR® Green FastMix per the 
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manufacturer’s protocol (Quanta). Ct values were normalized to RNU6. Cycling conditions 
were: 95°C (3:00min) followed by 40 cycles of 95 °C (5sec), 55°C(sec) , 72°C (7 sec). A melting 
curve was generated to indicate specific product production. Primers used were as follows; MiR-
199 primer (hsa-miR-199a-3p: ACAGUAGUCUGCACAUUGGUUA) IDT®, PerfeCTa® 
Universal PCR Primer, RNU6-1 
(GUGCUCGCUUCGGCAGCACAUAUACUAAAAUUGGAACGAUACAGAGAA 
GAUUAGCAUGGCCCCUGCGCAAGGAUGACACGCAAAUUCGUGAAGCGU 
UCCAUAUUUU) Quanta® and Lyn (5’-CGAAAGCTGGATAAAGCATGCG-3’ F) (5’-
CTGCTCTCAGGTCTCGGTGG-3’ R) Quanta®. At least three biological replicates were used 
per time point. Data were analyzed using the comparative Ct method87. 
Respiratory Burst Assay 
 
 A working solution of dihydrodichlorofluorescein (H2DCFDA) was prepared by 
combining, in a 1:1 ratio, H2DCFDA stock solution (1mg/mL in DMSO) with DMSO to a final 
concentration of 500µg/mL. A working solution of PMA was prepared in a 1:49 ratio of PMA to 
NFW for a final concentration of 20µg/mL. A dosing solution of H2DCFDA was prepared to fill 
48 wells with a final concentration of 1µg/mL of H2DCFDA in egg water. Another dosing 
solution of H2DCFDA + PMA was prepared to a final concentration of 400nL/mL PMA and 
1µg/mL H2DCFDA to fill the remaining 48 wells. All 96 wells were used and split into four 
conditions: control, miR-199 knockdown (KD), control + PMA, and miR-199 + PMA, using 1 
embryo per well. H2DCFDA in egg water dosing solution (100µL) was added to the first 48 
wells. To the remaining 48 wells, 100µL H2DCFDA + PMA solution was added. The plate was 
then covered with aluminum foil and incubated for 3 hrs at 28°C. Samples were read using a 
fluorescence microplate reader88,89. 
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Results: 
miR-199 is dysregulated within the zebrafish upon P. aeruginosa infection 
 Following RNAseq analysis, miR-199 was found to be upregulated in the zebrafish upon 
P. aeruginosa infection and CFTR knockdown (Figure 1). This result identified miR-199 as a 
miR that may be implicated in the innate immune response, as well CF. However, further 
analysis was necessary to confirm this preliminary hypothesis. 
  
Figure 3. RNAseq analysis identifies miR-199 as upregulated upon P. aeruginosa infection. 
Zebrafish were subjected to P. aeruginosa via duct of cuvier (DC) injection. RNA was isolated 
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at 6 hours post infection (hpi).  MiRs were binned based on high expression (> 10 log (counts per 
million)) and high fold change (> log 2).  
In order to confirm that P. aeruginosa was indeed influencing the expression of miR-199, 
we measured miR-199 expression as a result of P. aeruginosa infection alone, without the 
influence of CFTR knockdown. It was shown that miR-199 expression was significantly 
downregulated at 1hpi and significantly upregulated at 6 hpi (Fig. 4). The significant 
upregulation in response to bacterial infection at 6hpi further suggested a potential functional 
role for miR-199 in the innate immune system. 
 
 
Figure 4. miR-199 expression increases 2.4-fold upon P. aeruginosa infection. 2 days post 
fertilization (dpf) zebrafish embryos were mock-infected with PBS or infected with P. 
aeruginosa (p67T1) through tail vein injections to mimic systemic infection. RNA was isolated 
and converted to cDNA at 1, 3, and 6 hpi. qPCR was performed to analyze the expression of 
miR-199 upon bacterial infection.  
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MiR-199 expression is localized to the inner ear, heart, and anterior kidney  
  
 Previous studies have shown miR-199 expression in murine inner ear structures as well 
as murine and zebrafish hearts, specifically in cardiomyocytes, aortic/cardiac valves, and 
endocardial cells52–54,90. To observe the spatial and temporal expression of miR-199 in the 
developing zebrafish embryo before proceeding with function studies we performed in situ 
hybridization (ISH). As expected, due to the conserved nature of mature miRNA transcripts, 
miR-199 expression was highly expressed in the ear and heart regions throughout the time 
course, as indicated in purple (Figure 3). At 48 hpf the yolk syncytial layer (YSL) surrounding 
the yolk sac of the embryo displays high miR-199 expression. MiR-199 is also expressed in the 
anterior kidney, a region of hematopoetic stem cell origination, similar to the bone marrow in 
humans.  
 
Figure 5. In situ hybridization indicates that miR-199 expression is localized to the ear, 
heart and anterior kidney of the zebrafish. PTU treated embryos were fixed at 24, 48, 72, and 
96 hpf. Whole mount ISH was performed for the detection of mature miR-199 transcripts. 
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Susceptibility to Bacterial Infection Decreases upon Loss of MiR-199 
 
 MiR-199 is upregulated during systemic infections with P. aeruginosa and expressed in 
the anterior kidney of the zebrafish. We hypothesize a functional role for miR-199 in the context 
of innate immunity and implemented a reverse genetic approach to knockdown mature miR-199 
transcripts via miR-199 MO injection at the single cell stage of zebrafish development. Upon 
knockdown of miR-199, P. aeruginosa infected zebrafish showed a decreased bacterial burden at 
6hpi as well as an increased survival rate over the course of a 5-day infection. Over the 5-day 
survival observation there was no significant decrease in survival between the control and miR-
199 MO mock infected populations. However, miR-199 morphants displayed roughly a 50% 
increase in survival upon systemic P. aeruginosa infection compared to the controls (Figure 4).  
 
Figure 6. Knockdown of miR-199 via oligonucleotide morpholino decreases bacterial 
burden and increases overall survival of zebrafish systemically infected with P. aeruginosa. 
A.) Embryos were washed in 4 mg/ml tricaine solution 6 hpi. Single fish were then homogenized 
in 200 µl of PBS along with two 4.2 mm metal beads using a Bullet Blender at speed 8 for 2 
minutes (Next Advance). Homogenates were diluted in PBS and plated onto Cetrimide agar to 
	  
	  
32 
isolate P. aeruginosa colonies. Plates were incubated for 16 hours at 37 °C.  B.) Zebrafish were 
injected at the 1–2 cell stage with miR-199 MO or control MO. 48 hour post fertilization (hpf) 
the fish were subjected to bacterial infection. Control and miR-199 morphants were mock-
infected with PBS or infected with P. aeruginosa dTomato via tail vein injections. Embryos were 
screened using the Zeiss microscope to ensure systemic P. aeruginosa infection. Embryo 
survival was observed for 5 dpi. (Statistical analysis was determined using a Log-rank test (**** 
p<.0001,*** p<.001, ** p<.01). 
The Src Family Kinase (SFK) Lyn is a putative target of miR-199 
 A target scan was performed and SFK Lyn was identified as a potential target of miR-
199. Given the implications of Lyn in multiple biological pathways including those within the 
immune system, we performed a miR-199 KD and observed changes in Lyn expression. Upon 
miR-199 KD Lyn expression increased roughly 5-fold compared to the control.  
 
 Figure 7. Src Family Kinase (SFK) Lyn is a putative target of miR-199. Zebrafish 
embryos at the one cell stage of development were injected with control and miR-199 MO. RNA 
was isolated at 1day post injection and converted into cDNA. qPCR was performed using 
primers specific to the zebrafish Lyn gene.  
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Discussion: 
    
 
 Human health is continually being complicated by microbial antibiotic resistance and 
compromised host immunity. Gaining a better understanding of host immunity and gene 
regulation will help direct therapeutics and strategies to enhance the immune response. Targeting 
host genes avoids the selective pressures faced by therapeutics, such as antibiotics, that are 
directed against specific infectious agents. Profiling of aberrant gene expression during 
infections has the potential to identify unique functional roles for genes within the immune 
system. MiR research has provided insight into gene regulation mechanisms and may further 
help advance human therapeutic design. In this study, we seek to understand the role that miRs 
play on gene regulation in the context of the innate immune response.  
 As part of a large collaborative Centers of Biomedical Research Excellence (COBRE) 
project, multiple institutes sought to “Determine the effects of very low concentrations of 
Arsenic (As) on Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) expression and 
the innate immune response using a toxicogenomic approach”. There is evidence that CFTR is 
linked to the innate immune response, as mutations in CFTR result in increased susceptibility to 
lung infection by P. aeruginosa in humans. The zebrafish has been shown to be a useful model 
to study the host innate immune response and the pathogenesis of P. aeruginosa associated with 
CF73,91. One project goal was to identify unique miRs dysregulated by the various treatments of 
CFTR KD and/or As and investigate their role in innate immunity in vivo using the zebrafish 
model.  
 Deep sequencing analysis uncovered hundreds of aberrantly expressed miRs upon 
stimulation of the innate immune response. miRs were filtered based on high expression values 
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and increased or decreased log2FoldChange. miR-199 was identified as our miR of interest for 
further investigation in the context of innate immunity.  
Our initial investigation confirmed that miR-199 is upregulated in response to P. 
aeruginosa infection at 6 hpi (Fig. 4). Additionally, it was discovered via ISH that miR-199 
expression is localized to the ear, heart and anterior kidney of the zebrafish (Fig. 5). The kidney 
is the site of hematopoetic stem cell origination in the zebrafish and is similar to the bone 
marrow of humans. Taken together, these data support the likelihood that miR-199 is indeed 
involved in the innate immune response. However, the specific pathway targeted by miR-199 
remains to be fully understood. 
 In order to explore the role of miR-199, a functional approach was taken by 
implementing knockdown of miR-199 via morpholino injection at the 1-cell embryonic stage. 
Loss of miR-199 significantly decreased the susceptibility to P. aeruginosa infection and 
resulted in increased host survival after systemic infection (Fig. 6). Therefore, we hypothesized 
that loss of miR-199 may be regulating the function of phagocytes and their role in clearing 
infectious agents. Phagocytes play a vital role in clearing bacterial infection through 
phagocytosis and production of ROS. Zebrafish TargetScan identified the SFK Lyn as a potential 
target of miR-199. A recent study showed that Lyn knockdown using a Lyn morpholino had an 
inhibitory effect on the migration of neutrophils to the site of a wound in zebrafish.98 The study 
found that there was a roughly 30% decrease in neutrophils at the site of a wound upon 
knockdown of Lyn (Yoo et al). While the role of Lyn in response to wounds in the zebrafish has 
been investigated, studying the interaction between Lyn and miR-199 in response to bacterial 
infection provides a novel path for study. Although the relationship between miR-199 and Lyn	  is 
not fully understood, we hypothesize that miR-199 is targeting Lyn at the transcriptional level 
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and interfering with the signaling cascade responsible for activation of phagocytes, specifically 
neutrophils. 
Based on our observations, it is clear that miR-199 plays a role in the “fine-tuning” of the 
innate immune response in the zebrafish. The expression of miR-199 is clearly dysregulated 
upon stimulation of the innate immune system (Fig. 3). Although both decreased bacterial 
burden and increased survival are observed following miR-199 knockdown and P. aeruginosa 
infection, the biological mechanism underlying this result remains to be adequately described. 
Our preliminary results suggest that targeting of the SFK Lyn at the transcriptional level by miR-
199 may be causing a dampened innate immune response. Future research is necessary in order 
to confirm this hypothesis. One avenue of investigation that is of particular interest is to perform 
qPCR measuring the expression of Lyn upon miR-199 knockdown during the course of P. 
aeruginosa infection. Another important observation would be to utilize an MPX zebrafish 
transgenic line having GFP-labeled neutrophils. These MPX fish could be injected at the 1-cell 
stage of development with miR-199 MO and then locally infected with P. aeruginosa. The 
migration of neutrophils to the site of infection could then be observed real-time and it could be 
determined whether miR-199 knockdown was playing a role in neutrophil migration. This 
specific investigation has a great deal of potential to provide insight into the innate immune 
response.  
In conclusion, the investigation of aberrant miR expressions can help us gain a better 
understanding of gene regulation during the host innate immune response. If the specific role of 
miR-199 were completely understood, it could potentially serve as a novel therapeutic target for 
disease control in patients suffering from CF and chronic lung infection in which miR-199 
expression could be modulated in order to combat its immune dampening effects. 
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